EUVIMEDEUVIMED entdecken
Crossref

Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome

Siddhi Tiwari

Bioinformation · 31.10.2026 · 22 (10) · 6384-6389

DOI: 10.6026/973206300226384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Siddhi Tiwari.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Megaloblastic anemia and myelodysplastic syndrome can present with overlapping macrocytic anemia and cytopenias but require distinct management. Therefore, it is of interest to evaluate the diagnostic utility of bone marrow examination in 120 patients, comprising 70 with megaloblastic anemia and 50 with myelodysplastic syndrome, using clinical, hematological, biochemical and marrow findings. Megaloblastic anemia accounted for 58.3% of cases, while myelodysplastic syndrome accounted for 41.7%; patients with myelodysplastic syndrome were significantly older (63.4 +/- 10.8 vs. 41.8 +/- 12.6 years; p

Zitieren

APA

Tiwari, S. (2026). Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome. Bioinformation, 22(10), 6384-6389. https://doi.org/10.6026/973206300226384

Vancouver

Tiwari S. Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome. Bioinformation. 2026;22(10):6384-6389. doi:10.6026/973206300226384

BibTeX
@article{Tiwari2026,
  author = {Tiwari, Siddhi},
  title = {Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {6384--6389},
  doi = {10.6026/973206300226384}
}
Kostenlos starten →